GURUFOCUS.COM » STOCK LIST » USA » OTCPK » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Debt-to-Equity
Switch to:

Biomark Diagnostics (OTCPK:BMKDF) Debt-to-Equity

: -2.37 (As of Jun. 2022)
View and export this data going back to 2015. Start your Free Trial

Biomark Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.37 Mil. Biomark Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.40 Mil. Biomark Diagnostics's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $-0.32 Mil. Biomark Diagnostics's debt to equity for the quarter that ended in Jun. 2022 was -2.37.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Biomark Diagnostics's Debt-to-Equity or its related term are showing as below:

BMKDF' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.37   Med: -0.64   Max: -0.01
Current: -2.37

During the past 9 years, the highest Debt-to-Equity Ratio of Biomark Diagnostics was -0.01. The lowest was -2.37. And the median was -0.64.

BMKDF's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.28 vs BMKDF: -2.37

Biomark Diagnostics (OTCPK:BMKDF) Debt-to-Equity Historical Data

The historical data trend for Biomark Diagnostics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.02 -1.52 -1.65

Biomark Diagnostics Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -0.39 -2.06 -1.65 -2.37

Biomark Diagnostics (OTCPK:BMKDF) Debt-to-Equity Competitive Comparison

For the Diagnostics & Research subindustry, Biomark Diagnostics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Biomark Diagnostics (OTCPK:BMKDF) Debt-to-Equity Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Debt-to-Equity falls into.



Biomark Diagnostics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biomark Diagnostics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.34992101105845 + 0.47867298578199) / -0.50236966824645
=-1.65

Biomark Diagnostics's Debt to Equity Ratio for the quarter that ended in Jun. 2022 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.36863480162449 + 0.39753202124336) / -0.32333645735708
=-2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics  (OTCPK:BMKDF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Biomark Diagnostics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (OTCPK:BMKDF) Business Description

Biomark Diagnostics logo
Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.

Biomark Diagnostics (OTCPK:BMKDF) Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership